Page 336 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 336
EU Public Health (Cont.)
P1255 ACCESSING HEPATITIS CTESTING:WHO,WHAT,WHERE, AND
WHEN?
Ruth Simmons, Lukasz Cieply*, Sema Mandal, Sam Lattimore,
The United Kingdom
P1256 THE GLOBAL AND REGIONAL BURDEN OF LIVER
DISEASE, 2013
Benjamin C. Cowie*, Nicole Allard, Jennifer H. MacLachlan,
Neeraj Bhala, Australia
P1257 EARLY IDENTIFICATION OF PATIENTS AT RISK FOR
CHRONIC HEPATITIS B AND C IN ARNHEM REGION,
NETHERLANDS
Gerjanne Ter Beest*, Jet Gisolf, Maarten Belgers, Toos Waegemaeckers,
Caroline Swanink, Marcel Spanier, Jan Maarten Vrolijk,
Petra Van Bentum, Lian Roovers, Clemens Richter, The Netherlands
P1258 PREVALENCE OF SIGNIFICANT HEPATIC FIBROSIS AND
CIRRHOSIS ASSESSED BY THE NAFLD FIBROSIS SCORE IN
ePOSTERS PATIENTS ATTENDING THE DIABETIC CLINIC
Jun Liong Chin, Grace Chan*, Phyllis Sea-Pui Sin, Zeshan Siddiqui,
Eoin O’Rathallaigh, Abdur Rahman Aftab, Garry Courtney,
Colm McGurk, Ireland
P1259 HEPATITIS B IN PREGNANCY IN UKRAINE:
WASTED CHANCE
Inna Kravchuk, Nina F. Chumak, Robert R. Schade*, Iryna S. Hepburn,
The United States
P1260 PERCEPTIONS OF VIRAL HEPATITIS TESTING IN MIGRANT
COMMUNITIES AND THE PRIMARY CARE PHYSICIANS
THAT SERVE THEM
Sanju Mathew*, Mihaela Petrova, Jane Hendy, Simon de Lusignan,
Joanne Zamani, Ramji Tiwari, Margot Nicholls, Patrick Kennedy,
Graham Foster, Aftab Ala, The United Kingdom
P1261 SPECIFIC PATTERNS OF DRUG CO-USE INCREASE RISK
FOR HEPATITIS C VIRUS INFECTION IN PEOPLE WHO
INJECT DRUGS
Svetlana Puzhko*, Élise Roy, Didier Jutras-Aswad, Geng Zang,
Andrea A. Artenie, Julie Bruneau, Canada
336 The International Liver Congress™ 2015 • ILC Programme
P1255 ACCESSING HEPATITIS CTESTING:WHO,WHAT,WHERE, AND
WHEN?
Ruth Simmons, Lukasz Cieply*, Sema Mandal, Sam Lattimore,
The United Kingdom
P1256 THE GLOBAL AND REGIONAL BURDEN OF LIVER
DISEASE, 2013
Benjamin C. Cowie*, Nicole Allard, Jennifer H. MacLachlan,
Neeraj Bhala, Australia
P1257 EARLY IDENTIFICATION OF PATIENTS AT RISK FOR
CHRONIC HEPATITIS B AND C IN ARNHEM REGION,
NETHERLANDS
Gerjanne Ter Beest*, Jet Gisolf, Maarten Belgers, Toos Waegemaeckers,
Caroline Swanink, Marcel Spanier, Jan Maarten Vrolijk,
Petra Van Bentum, Lian Roovers, Clemens Richter, The Netherlands
P1258 PREVALENCE OF SIGNIFICANT HEPATIC FIBROSIS AND
CIRRHOSIS ASSESSED BY THE NAFLD FIBROSIS SCORE IN
ePOSTERS PATIENTS ATTENDING THE DIABETIC CLINIC
Jun Liong Chin, Grace Chan*, Phyllis Sea-Pui Sin, Zeshan Siddiqui,
Eoin O’Rathallaigh, Abdur Rahman Aftab, Garry Courtney,
Colm McGurk, Ireland
P1259 HEPATITIS B IN PREGNANCY IN UKRAINE:
WASTED CHANCE
Inna Kravchuk, Nina F. Chumak, Robert R. Schade*, Iryna S. Hepburn,
The United States
P1260 PERCEPTIONS OF VIRAL HEPATITIS TESTING IN MIGRANT
COMMUNITIES AND THE PRIMARY CARE PHYSICIANS
THAT SERVE THEM
Sanju Mathew*, Mihaela Petrova, Jane Hendy, Simon de Lusignan,
Joanne Zamani, Ramji Tiwari, Margot Nicholls, Patrick Kennedy,
Graham Foster, Aftab Ala, The United Kingdom
P1261 SPECIFIC PATTERNS OF DRUG CO-USE INCREASE RISK
FOR HEPATITIS C VIRUS INFECTION IN PEOPLE WHO
INJECT DRUGS
Svetlana Puzhko*, Élise Roy, Didier Jutras-Aswad, Geng Zang,
Andrea A. Artenie, Julie Bruneau, Canada
336 The International Liver Congress™ 2015 • ILC Programme
